Joao D. Silva-Barros

Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Intra-promoter switch of transcription initiation sites in proliferation signaling-dependent RNA metabolism.

Intra-promoter switch of transcription initiation sites in proliferation signaling-dependent RNA metabolism.

Journal: Nature structural & molecular biology
Published: January 30, 2023

Patient Derived Organoids Confirm That PI3K/AKT Signalling Is an Escape Pathway for Radioresistance and a Target for Therapy in Rectal Cancer.

Patient Derived Organoids Confirm That PI3K/AKT Signalling Is an Escape Pathway for Radioresistance and a Target for Therapy in Rectal Cancer.

Journal: Frontiers in oncology
Published: April 14, 2022

Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden.

Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden.

Journal: Radiation oncology (London, England)
Published: March 13, 2021

Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors.

Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors.

Journal: Cancers
Published: April 16, 2020

Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer.

Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer.

Journal: European urology oncology
Published: May 19, 2018

Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer.

Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer.

Journal: Cell reports
Published: January 15, 2018

Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG.

Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG.

Journal: Translational oncology
Published: August 09, 2016

NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer.

NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer.

Journal: Genes, chromosomes & cancer
Published: October 01, 2015

Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements.

Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements.

Journal: Oncoscience
Published: January 06, 2015

Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.

Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.

Journal: Oncotarget
Published: July 25, 2014

Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing.

Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing.

Journal: Translational oncology
Published: June 10, 2013

Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis.

Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis.

Journal: Journal of cellular and molecular medicine
Published: February 11, 2013
Showing 1-12 of 17

Last Updated: 09/26/2026